VALBIOTIS announces additional positive results from phase IIA clinical study of VALEDIA

This article was originally published here

Topline data from the study were published on 3 July 20191, which showed a significant reduction in hyperglycemia, body weight and waist size compared to placebo. The entire

The post VALBIOTIS announces additional positive results from phase IIA clinical study of VALEDIA appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply